Glenmark Pharmaceuticals532296Pharmaceuticals
Nomura retained buy call on Glenmark Pharma with stock up about 4.8%, raising target price to 3,750 rupees from 3,300 rupees
- Stock move
- 4.8 percent
- New target price
- 3750 rupees
- Previous target price
- 3300 rupees
Heard on business television between 15:46:15 - 15:49:15 IST.
- Stock rose about 4.8% on the day.
- Nomura retained buy rating, raised target price to 3,750 rupees from 3,300 rupees.
- Cited strategic reset backed by Fosun.
- Brokerage sees four key pillars: CDMO contracts, joint business development between Glenmark and Cxi, and entry into new areas.
Watch at source
behind live
- 1Open on YouTube
- 2Drag the seek bar left
- 3Watch this moment
Also from Glenmark Pharmaceuticals
US arm launches pump packs for Adapalene Gel USP, 0.1% (OTC)
6 Oct 2026
Source: Live TV News Channel · 7 Oct 2026
The call above is Nomura's, reported here as they made it. Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.